Showing results (151-160 of 332) with videos related to
Sort By:
Pageof 34
Neurology(R) Neuroimmunology & Neuroinflammation|August 28, 2023
Kappa Free Light Chain Index Predicts Disease Course in Clinically and Radiologically Isolated SyndromesMichael Levraut, Antoine Gavoille, Cassandre Landes-Chateau, et al.Neurology(R) Neuroimmunology & Neuroinflammation|December 15, 2019
Frequency of myelin oligodendrocyte glycoprotein antibody in multiple sclerosis: A multicenter cross-sectional studyÁlvaro Cobo-Calvo, Hyacintha d'Indy, Anne Ruiz, et al.Neurology(R) Neuroimmunology & Neuroinflammation|November 16, 2016
Risk of relapse after natalizumab withdrawal: Results from the French TYSEDMUS cohortCaroline Papeix, Sandra Vukusic, Romain Casey, et al.Journal of Neurology|January 13, 2005
European validation of a standardized clinical description of multiple sclerosisMaria Pia Amato, Jerome Grimaud, Iuliana Achiti, et al.Multiple Sclerosis and Related Disorders|January 18, 2019
Single-arm study to assess comprehensive infusion guidance for the prevention and management of the infusion associated reactions (IARs) in relapsing-remitting multiple sclerosis (RRMS) patients treated with alemtuzumab (EMERALD)Sandra Vukusic, David Brassat, Jerome de Seze, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2015
Multiple sclerosis lesion formation and early evolution revisited: A weekly high-resolution magnetic resonance imaging studyCharles Rg Guttmann, Matthieu Rousset, Jean A Roch, et al.Journal of Neurology|June 9, 2025
Monitoring anti-Rituximab antibodies in myasthenia gravis affects the time to event during Rituximab treatmentCharlotte Héraud, Saskia Bresch, Véronique Bourg, et al.Multiple Sclerosis and Related Disorders|July 18, 2021
Should we still only rely on EDSS to evaluate disability in multiple sclerosis patients? A study of inter and intra rater reliabilityMikael Cohen, Saskia Bresch, Océane Thommel Rocchi, et al.Multiple Sclerosis and Related Disorders|March 20, 2015
High doses of biotin in chronic progressive multiple sclerosis: a pilot studyFrédéric Sedel, Caroline Papeix, Agnès Bellanger, et al.Plos One|November 28, 2017
Decreased prevalence of cancer in patients with multiple sclerosis: A case-control studyXavier Moisset, Maud Perié, Bruno Pereira, et al.Pageof 34